Lv6
2930 积分 2022-11-05 加入
Trastuzumab emtansine for patients with non–small cell lung cancer positive for human epidermal growth factor receptor 2 exon-20 insertion mutations
23天前
已关闭
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study
24天前
已关闭
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
27天前
已完结
Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial
1个月前
已完结
Experiences of Teaching and Learning Pediatric Pain Management in Ghana
1个月前
已完结
TACE plus immune checkpoint inhibitor-based systemic therapies for hepatocellular carcinoma
1个月前
已完结
Selected pharmacologic characteristics of idarubicin and idarubicinol
2个月前
已关闭
Chemoradiotherapy and Subsequent Immunochemotherapy as Conversion Therapy in Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase II NEXUS-1 Trial
2个月前
已完结
Acute myeloid leukaemia
2个月前
已完结
晚期子宫内膜癌新辅助化疗
3个月前
已完结
皖公网安备34019202002308
